Illumina Supports Norway's Pioneering Precision Medicine Study
/PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN), today announced that it is supporting a national precision medicine study in Norway to assess the efficacy of...
Stay updated with breaking news from Precision Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN), today announced that it is supporting a national precision medicine study in Norway to assess the efficacy of...
/PRNewswire/ -- Denovo Biopharma LLC and QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a collaboration to develop a blood-based companion...
/PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN), today announced that it is supporting a national precision medicine study in Norway to assess the efficacy of...
Dublin, Dec. 09, 2021 (GLOBE NEWSWIRE) -- The "US Value-based Care: Trends & Business Implications for Medical Device Companies" report has been...
The company will support a 500-patient study of genomic profiling for cancer therapy selection with sequencing reagents and other resources.